Ispire Malaysia Attains ISO Certification, Avoiding 25% Transportation Tariffs
According to an announcement on the official website of Ispire on January 4th, the company has declared that its Malaysian subsidiary, Ispire Malaysia Sdn Bhd, has successfully obtained certifications for ISO9001:2015 Quality Management System, ISO14001:2015 Environmental Management System, and ISO13485:2016 Medical Device Quality Management System for its manufacturing facility in Malaysia.
Michael Wang, the CEO of the company, stated that having our own factory will allow us to achieve greater profits in product assembly. Furthermore, the products produced by our company in Malaysia and shipped to the United States are not affected by tariffs, which creates favorable conditions for increasing gross profit margins.
Michael Wang stated, "We have received our initial orders and are rapidly entering the production preparation phase. By establishing production facilities in Malaysia, we not only avoid the 25% tariffs incurred from shipping from China, but also improve our gross profit margin."
In order to reduce tariff costs, it is predicted that Ispire will further shift its production processes to Malaysia.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
